Tailoring Treatment in Polymorbid Migraine Patients Through Personalized Medicine

Overview

Journal CNS Drugs

Specialties Neurology
Pharmacology

Date 2018 Jun 22

PMID 29926370

Citations 7

Authors

Leda Marina Pomes

Giovanna Gentile

Maurizio Simmaco

Marina Borro

Paolo Martelletti

Affiliations

Soon will be listed here.

Citing Articles

Magnetoencephalography studies in migraine and headache disorders: A systematic review.

Gopalakrishnan R, Malan N, Mandava N, Dunn E, Nero N, Burgess R Headache. 2024; 65(2):353-366.

PMID: 39523760 PMC: 11794981. DOI: 10.1111/head.14867.

New Migraine Drugs for Older Adults.

Onan D, Wells-Gatnik W, Bentivegna E, Lampl C, Martelletti P Drugs Aging. 2023; 40(4):301-305.

PMID: 36826751 DOI: 10.1007/s40266-023-01012-w.

Pharmacogenetics in Primary Headache Disorders.

Belyaeva I, Subbotina A, Eremenko I, Tarasov V, Chubarev V, Schioth H Front Pharmacol. 2022; 12:820214.

PMID: 35222013 PMC: 8866828. DOI: 10.3389/fphar.2021.820214.

Current and emerging evidence-based treatment options in chronic migraine: a narrative review.

Agostoni E, Barbanti P, Calabresi P, Colombo B, Cortelli P, Frediani F J Headache Pain. 2019; 20(1):92.

PMID: 31470791 PMC: 6734211. DOI: 10.1186/s10194-019-1038-4.

Optimising migraine treatment: from drug-drug interactions to personalized medicine.

Pomes L, Guglielmetti M, Bertamino E, Simmaco M, Borro M, Martelletti P J Headache Pain. 2019; 20(1):56.

PMID: 31101004 PMC: 6734220. DOI: 10.1186/s10194-019-1010-3.

References

de Tommaso M, Sciruicchio V, Delussi M, Vecchio E, Goffredo M, Simeone M . Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: an observational study in a tertiary headache center. J Headache Pain. 2017; 18(1):59. PMC: 5449358. DOI: 10.1186/s10194-017-0764-8. View

Gentile G, Chiossi L, Lionetto L, Martelletti P, Borro M . Pharmacogenetic insights into migraine treatment in children. Pharmacogenomics. 2014; 15(11):1539-50. DOI: 10.2217/pgs.14.104. View

Krymchantowski A, Bigal M . Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach. Expert Rev Neurother. 2006; 6(3):283-9. DOI: 10.1586/14737175.6.3.283. View

Borro M, Gentile G, Cipolloni L, Foldes-Papp Z, Frati P, Santurro A . Personalised Healthcare: The DiMA Clinical Model. Curr Pharm Biotechnol. 2017; 18(3):242-252. DOI: 10.2174/1389201018666170208125131. View

Hellum B, Hu Z, Nilsen O . The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin Pharmacol Toxicol. 2007; 100(1):23-30. DOI: 10.1111/j.1742-7843.2007.00011.x. View

Yale S, Glurich I . Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med. 2005; 11(3):433-9. DOI: 10.1089/acm.2005.11.433. View

Palleria C, Di Paolo A, Giofre C, Caglioti C, Leuzzi G, Siniscalchi A . Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci. 2014; 18(7):601-10. PMC: 3897029. View

Gaudineau C, Beckerman R, Welbourn S, Auclair K . Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem Biophys Res Commun. 2004; 318(4):1072-8. DOI: 10.1016/j.bbrc.2004.04.139. View

Hagen K, Asberg A, Uhlig B, Tronvik E, Brenner E, Stjern M . The epidemiology of headache disorders: a face-to-face interview of participants in HUNT4. J Headache Pain. 2018; 19(1):25. PMC: 5859006. DOI: 10.1186/s10194-018-0854-2. View

10.

Steiner T, Stovner L, Vos T, Jensen R, Katsarava Z . Migraine is first cause of disability in under 50s: will health politicians now take notice?. J Headache Pain. 2018; 19(1):17. PMC: 5821623. DOI: 10.1186/s10194-018-0846-2. View

11.

Rainero I, Govone F, Gai A, Vacca A, Rubino E . Is Migraine Primarily a Metaboloendocrine Disorder?. Curr Pain Headache Rep. 2018; 22(5):36. DOI: 10.1007/s11916-018-0691-7. View

12.

Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A . DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2010; 39(Database issue):D1035-41. PMC: 3013709. DOI: 10.1093/nar/gkq1126. View

13.

Borro M, Simmaco M, Aceti A, Barni S, De Luca A, Fineschi V . H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine. Curr Pharm Biotechnol. 2016; 17(10):926-9. DOI: 10.2174/1389201017666160519112850. View

14.

Lionetto L, Gentile G, Bellei E, Capi M, Sabato D, Marsibilio F . The omics in migraine. J Headache Pain. 2013; 14:55. PMC: 3727988. DOI: 10.1186/1129-2377-14-55. View

15.

Lionetto L, Borro M, Curto M, Capi M, Negro A, Cipolla F . Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations. Expert Opin Drug Metab Toxicol. 2016; 12(4):399-406. DOI: 10.1517/17425255.2016.1154042. View

16.

Ferrari A, Baraldi C, Licata M, Rustichelli C . Polypharmacy Among Headache Patients: A Cross-Sectional Study. CNS Drugs. 2018; 32(6):567-578. PMC: 6061427. DOI: 10.1007/s40263-018-0522-8. View

17.

Deng Y, Bi H, Zhao L, Wang X, Chen J, Ou Z . Induction of cytochrome P450 3A by the Ginkgo biloba extract and bilobalides in human and rat primary hepatocytes. Drug Metab Lett. 2009; 2(1):60-6. DOI: 10.2174/187231208783478489. View

18.

Silberstein S, Dodick D, Freitag F, Pearlman S, Hahn S, Scher A . Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy. Headache. 2007; 47(4):585-99. DOI: 10.1111/j.1526-4610.2007.00760.x. View

19.

Pirmohamed M, James S, Meakin S, Green C, Scott A, Walley T . Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004; 329(7456):15-9. PMC: 443443. DOI: 10.1136/bmj.329.7456.15. View

20.

van Os H, Mulder I, Broersen A, Algra A, van der Schaaf I, Kappelle L . Migraine and Cerebrovascular Atherosclerosis in Patients With Ischemic Stroke. Stroke. 2017; 48(7):1973-1975. DOI: 10.1161/STROKEAHA.116.016133. View